News
31mon MSN
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...
5d
MedPage Today on MSNRecent Developments in Bladder CancerFrom a biomarker-driven strategy to delay or avoid cystectomy, to practice-changing perioperative immunotherapy, developments ...
4h
NBC Los Angeles on MSNSoCal doctors successfully perform world's first in-human bladder transplantA California cancer survivor was the recipient of the world’s first in-human bladder transplant this month thanks to a pair ...
Bladder cancer, a common malignancy, often presents subtle symptoms like blood in urine or painful urination.
About 40 percent of cancer cases are considered preventable. Try these lifestyle changes to stay healthy.
Alan faced the prospect of losing his bladder when he was diagnosed with bladder cancer in 2020. Now he’s in remission thanks ...
Agilis Robotics Achieves Milestone with World's First Robotic-Assisted En Bloc Resection of Bladder Tumour in Collaboration ...
Cambridge: AstraZeneca has announced that Imfinzi (durvalumab) has been recommended for approval in the European Union (EU) for the treatment of adult patients with resectable ...
13hon MSN
These studies underscore the power of Veracyte, Inc. (NASDAQ:VCYT)’s whole-transcriptome-based GRID platform, which now ...
Analyst Selvaraju downgrades UroGen after FDA panel setback dims approval prospects for key bladder cancer drug UGN-102.
The CISTO study is the only going prospective study comparing radical cystectomy vs bladder-sparing options for high-grade NMIBC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results